|
|
Volumn 90, Issue 4, 2010, Pages 411-
|
|
Simvastatin in psoriasis: Ambiguous effects
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETAMETHASONE VALERATE;
CALCIPOTRIOL;
MOMETASONE FUROATE;
SIMVASTATIN;
ANTIINFLAMMATORY AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CLINICAL ARTICLE;
DISEASE ACTIVITY;
DRUG EFFECT;
DRUG TOLERABILITY;
DYSLIPIDEMIA;
HUMAN;
HYPERCHOLESTEROLEMIA;
LETTER;
LOCAL THERAPY;
PILOT STUDY;
PRIORITY JOURNAL;
PSORIASIS;
TREATMENT RESPONSE;
COMPLICATION;
ORAL DRUG ADMINISTRATION;
SEVERITY OF ILLNESS INDEX;
TIME;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ANTI-INFLAMMATORY AGENTS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
PILOT PROJECTS;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
SIMVASTATIN;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 77954901722
PISSN: 00015555
EISSN: None
Source Type: Journal
DOI: 10.2340/00015555-0852 Document Type: Letter |
|
Times cited : (7)
|
|
References (7)
|
